CG Oncology chief commercial officer Isabel Kalofonos reports acquisition of $299,161.005 in common shares
CGON•Chief Commercial Officer Isabel Kalofonos purchased 3,751 CG Oncology common shares at $79.755 per share, bringing indirect beneficial ownership through a trust to 3,751 shares.




